CU23563A3 - DERIVATIVES OF (TIO) CARBAMOIL-CICLOHEXANO AS ANTAGONISTS OF THE RECEIVER D3 / D2 - Google Patents
DERIVATIVES OF (TIO) CARBAMOIL-CICLOHEXANO AS ANTAGONISTS OF THE RECEIVER D3 / D2Info
- Publication number
- CU23563A3 CU23563A3 CU20060024A CU20060024A CU23563A3 CU 23563 A3 CU23563 A3 CU 23563A3 CU 20060024 A CU20060024 A CU 20060024A CU 20060024 A CU20060024 A CU 20060024A CU 23563 A3 CU23563 A3 CU 23563A3
- Authority
- CU
- Cuba
- Prior art keywords
- ciclohexano
- carbamoil
- antagonists
- tio
- derivatives
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 abstract 1
- 108091007265 Dopamine D2-Like Receptors Proteins 0.000 abstract 1
- 108090000525 Dopamine D3 Receptors Proteins 0.000 abstract 1
- 108050004812 Dopamine receptor Proteins 0.000 abstract 1
- 102000015554 Dopamine receptor Human genes 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003435 aroyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La actual invención se relaciona con los ligandos de la fórmula (I) que prefieren los nuevos subtipos receptores de dopamina D3 y D2: en el que R1 y R2 representan independientemente un sustituyente seleccionado a partir del hidrógeno, alquilo, arilo, cicloalquilo, aroilo, o R1 y R2 pueden formar un anillo heterocíclico con el átomo adyacente de nitrógeno; X representa a un átomo de oxígeno o azufre; n constituye un número entero desde 1 hasta 2 y/o isómeros geométricos y/o estereoisómeros y/o diastereómeros y/o sales y/o hidratos y/o solvatos de los mismos, en los procesos para producir los mismos, en las composiciones farmacéuticas que contengan los mismos y en su empleo en la terapia y/o prevención de una afección que requiera la modulación de los receptores de dopamina. ESPACIO PARA FÓRMULAThe present invention relates to the ligands of the formula (I) that prefer the new dopamine D3 and D2 receptor subtypes: in which R1 and R2 independently represent a substituent selected from hydrogen, alkyl, aryl, cycloalkyl, aroyl, or R1 and R2 can form a heterocyclic ring with the adjacent nitrogen atom; X represents an oxygen or sulfur atom; n constitutes an integer from 1 to 2 and / or geometric isomers and / or stereoisomers and / or diastereomers and / or salts and / or hydrates and / or solvates thereof, in the processes for producing them, in pharmaceutical compositions that contain them and in their use in therapy and / or prevention of a condition that requires the modulation of dopamine receptors. FORMULA SPACE
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20060024A CU23563A3 (en) | 2006-02-03 | 2006-02-03 | DERIVATIVES OF (TIO) CARBAMOIL-CICLOHEXANO AS ANTAGONISTS OF THE RECEIVER D3 / D2 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20060024A CU23563A3 (en) | 2006-02-03 | 2006-02-03 | DERIVATIVES OF (TIO) CARBAMOIL-CICLOHEXANO AS ANTAGONISTS OF THE RECEIVER D3 / D2 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU23563A3 true CU23563A3 (en) | 2010-08-30 |
Family
ID=43302548
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20060024A CU23563A3 (en) | 2006-02-03 | 2006-02-03 | DERIVATIVES OF (TIO) CARBAMOIL-CICLOHEXANO AS ANTAGONISTS OF THE RECEIVER D3 / D2 |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU23563A3 (en) |
-
2006
- 2006-02-03 CU CU20060024A patent/CU23563A3/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN07255A1 (en) | Cyclohexylamides as dopamine d3, d2 and 5ht 1a antagonists | |
| CY1113099T1 (en) | CARBAMOYL-CYCLOEXANEI PRODUCT (SULFUR) AS D3 / D2 RECEPTOR COMPONENTS | |
| AR072488A1 (en) | 1,2,4-TRIAZOL HETEROCICLIC DERIVATIVES, BETA 2 ADRENERGIC RECEIVER AGONISTS AND COLINERGIC MUSCARINIC ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEMSELVES AND USES OF THE SAME IN THE TREATMENT OF RESPIRATORY AND INFLATORY AFFECTION. | |
| AR062111A1 (en) | DERIVATIVES OF BETA-D-GLUCOPIRANOSIL INDOL, METHOD OF PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES AS ANTI-DIABETIC AGENTS. | |
| CU20200051A7 (en) | BICYCLIC HETEROCYCLIC COMPONENTS REPLACED AS PRMT5 INHIBITORS | |
| CR11653A (en) | NEW INHIBITING CARBAZOL DERIVATIVES OF HSP90, COMPOSITIONS THAT CONTAIN THEM AND USE | |
| NI201000109A (en) | DERIVATIVES BIS- (SULFONYLAMINE) FOR USE IN THERAPY. | |
| MX2022000939A (en) | MACROCYCLIC COMPOUNDS AS STING AGONISTS AND METHODS AND USES THEREOF. | |
| AR088226A1 (en) | HETEROCICLIC PIPERIDINIC DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USE OF THE SAME FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | |
| AR071523A1 (en) | FUSIONATED BICYCLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION, THE COMPOSITE TO BE USED AS A MEDICINAL PRODUCT IN THE TREATMENT AND PROFILAXIS OF DISEASES, A PHARMACEUTICAL COMPOSITION AND A SET THAT INCLUDES SEPARATE PACKAGES OF THE COMPOUND AND OF AN INGREDIENT | |
| CR9459A (en) | BENZODIOXAN AND BENZODIOXOLAN DERIVATIVES AND USES OF THE SAME | |
| SV2010003459A (en) | PIRIMIDINE DERIVATIVES 934 | |
| MX2017003940A (en) | NR2B NEGATIVE ALOSTERIC MODULATORS OF N-ALQUILARIL-5-OXIARI L-OCTAHIDRO-CICLOPENTA [C] PIRROL. | |
| MX2009003383A (en) | NEW DERIVATIVES OF DIOSMETINE, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| ECSP12011916A (en) | DERIVATIVES OF PIRIDINO-PIRIDINONAS, | |
| NI200900147A (en) | NEW TRICYCLIC DERIVATIVES THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
| NI200900179A (en) | PIRIMIDINIL - PIPERAZINES USEFUL AS DOPAMINE D3 / D2 RECEPTOR LIGANDS. | |
| MX389378B (en) | NOVEL AMINO-IMIDAZOPYRIDINE DERIVATIVES AS JANUS KINASE INHIBITORS AND THEIR PHARMACEUTICAL USE. | |
| CL2020001817A1 (en) | C5a receptor modulators | |
| AR071721A1 (en) | DERIVATIVES OF PIRIDIL-PROLINAMIDE, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND ITS USE FOR THE TREATMENT OF ANXIETY, DEPRESSION AND DISORDERS OF THE SOUND. | |
| MX2017012387A (en) | Tricyclic fused derivatives of 1-(cyclo)alkyl pyridin-2-one useful for the treatment of cancer. | |
| CU20100073A7 (en) | NEW NON-PEPTIDIC DERIVATIVES AS B1 ANTAGONISTS OF BRADIQUININA | |
| TW200800962A (en) | Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions | |
| CU23563A3 (en) | DERIVATIVES OF (TIO) CARBAMOIL-CICLOHEXANO AS ANTAGONISTS OF THE RECEIVER D3 / D2 | |
| AR061740A1 (en) | NEW NAFTALENIC DERIVATIVES, THEIR PRAPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant of patent |